INDP Other: a positive outcome, +8.4%

On October 20, 2026, Indaptus Therapeutics, Inc. reached its Other. The result was a positive outcome, and the stock moved +8.4% in the window around the event. It had already run -25.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.